Since inception, the Foundation has provided over $540,000 in grants to specific researchers focusing on brain tumors/cancer, with much emphasis on GBMs, the deadliest of the brain tumors. Our grants have allowed researchers to prove their concept and submit their research to the NIH for million dollar grants. Our hope is that a project we helped fund opens the door to longer life expectancy and higher quality of life for those diagnosed with brain cancer. While advances have been made in breast, lung, colorectal cancers and Leukemia, little advancement has been made for glioblastoma brain tumors, with the average life expectancy of 12-18 months after diagnosis. Our research commitment the last 6 years has been for cutting edge research by Dr. Karen Fink, BaylorScott & White downtown Dallas. Dr. Fink is also a member of the Brain Tumor Trials Collaborative (BTTC) through the National Cancer Institute. Formed in 2003, the BTTC focuses on accelerating the pace of research by turning positive laboratory findings into clinical trials, then evaluating the impact of different therapies by measuring patient outcomes. Dr. Karen Fink with Baylor joins researchers from UT MD Anderson, UT Southwestern, The Cleveland Clinic, Cedars-Sinai and others, sharing research outcomes to advance the studies of all for the benefit of patients.
As we prepare for the annual upcoming event, we need corporate sponsors to help offset expenses of the event and increase net revenue for the 2024 research grants. We also need volunteers to help call upon local businesses for sponsorships and IN KIND Donations for our silent and live auctions.